USNA vs. HLF, NUS, NATR, MED, VERU, EL, IPAR, PBH, CRON, and CDXC
Should you be buying USANA Health Sciences stock or one of its competitors? The main competitors of USANA Health Sciences include Herbalife (HLF), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Cronos Group (CRON), and ChromaDex (CDXC).
USANA Health Sciences vs. Its Competitors
Herbalife (NYSE:HLF) and USANA Health Sciences (NYSE:USNA) are both small-cap personal products companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.
Herbalife has a net margin of 5.66% compared to USANA Health Sciences' net margin of 3.98%. USANA Health Sciences' return on equity of 8.94% beat Herbalife's return on equity.
Herbalife has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.63, meaning that its share price is 37% less volatile than the S&P 500.
54.3% of USANA Health Sciences shares are held by institutional investors. 1.7% of Herbalife shares are held by company insiders. Comparatively, 0.6% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Herbalife had 2 more articles in the media than USANA Health Sciences. MarketBeat recorded 3 mentions for Herbalife and 1 mentions for USANA Health Sciences. USANA Health Sciences' average media sentiment score of 1.60 beat Herbalife's score of 0.08 indicating that USANA Health Sciences is being referred to more favorably in the news media.
Herbalife has higher revenue and earnings than USANA Health Sciences. Herbalife is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.
Herbalife currently has a consensus price target of $11.50, suggesting a potential upside of 38.02%. USANA Health Sciences has a consensus price target of $36.00, suggesting a potential upside of 16.72%. Given Herbalife's stronger consensus rating and higher possible upside, equities research analysts clearly believe Herbalife is more favorable than USANA Health Sciences.
Summary
Herbalife beats USANA Health Sciences on 11 of the 16 factors compared between the two stocks.
Get USANA Health Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for USNA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding USNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
USANA Health Sciences Competitors List
Related Companies and Tools
This page (NYSE:USNA) was last updated on 6/27/2025 by MarketBeat.com Staff
